Article Sidebar
Published:
Jul 19, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Enhancement of solubility and release profile of simvastatin by co-crystallization with citric acid
Abstract
Purpose: To enhance the solubility and dissolution profile of simvastatin (SIM) via co-crystallization with varying levels of citric acid using various techniques.
Method: Simvastatin-citric acid (SIM-CA) co-crystals were prepared using dry grinding, slurry, liquidassisted grinding, and solvent evaporation techniques, and their various properties were compared. A total of twelve formulations (CC01 to CC12) were prepared. Optimized formulations were selected on the basis of dissolution profiles. Flow properties were evaluated using micromeritic analysis, yielding angle of repose, Carr’s index and Hausner’s ratio. Zeta sizer was employed to evaluate particle size distribution, while surface morphology was determined using scanning electron microscopy (SEM). Melting temperature, stability and physical interaction of simvastatin-citric acid co-crystals were determined by thermal analysis and FTIR. The crystalline nature of the co-crystals was evaluated by powder x-ray diffraction analysis, while solubility and dissolution studies were performed to determine in vitro drug release behavior.
Results: Micromeritic analysis revealed good flow properties of SIM-CA co-crystals. Results of Zeta sizer analysis showed that the particle sizes of the co-crystals were in the nanometer range, while SEM revealed that the co-crystals had regular cubical shape. Thermal stability studies with TGA and DSC showed that the co-crystals were stable at temperatures exceeding 400 oC. FTIR results revealed minor shifts in 2956 and 1706 cm-1 peaks. Co-crystal formation was confirmed by PXRD data. The drug release profiles of the optimized formulations (CC02, CC07 and CC11) were 11.36 - 94.46, 12.36 - 95.46 and 13.36 - 96.46 %, respectively. There was significant improvement in solubilities of the optimum formulations, with values of 310.18, 427.21 and 522.02 % for CC02, CC07 and CC11, respectively.
Conclusion: Citric acid improves the solubility and dissolution profile of the poorly water-soluble drug, simvastatin, which suggests that co-crystallization can potentially enhance the bioavailability of the drug.
